+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Allergy Treatment Market - Global Forecast 2026-2032- Product Image
Allergy Treatment Market - Global Forecast 2026-2032- Product Image
Sale

Allergy Treatment Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887880
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Allergy Treatment Market is projected to reach USD 36.35 Billion in 2026. It is expected to continue growing at a CAGR of 9.19%, reaching USD 62.69 Billion by 2032.

Allergy treatment encompasses medicines, immunotherapies, diagnostics, and supportive interventions for conditions such as allergic rhinitis, asthma-related allergy, atopic dermatitis, food allergy, and drug hypersensitivity. Demand is shaped by disease prevalence, environmental exposure, diagnostic access, clinical guidelines, patient adherence, and the availability of prescription and nonprescription care. The landscape is increasingly centered on personalized treatment selection, earlier diagnosis, long-term disease control, and safer management of severe reactions.

Transformative Shifts Reshaping Allergy Treatment

The field is moving from episodic symptom relief toward integrated, patient-centered management. Greater use of molecular and component-resolved diagnostics is helping clinicians distinguish sensitization patterns and refine treatment choices, while subcutaneous and sublingual immunotherapy continue to support disease modification for selected patients. Digital consultations, connected monitoring, and pharmacist-led care are improving access, although regulatory variation, affordability, adherence, and uneven specialist capacity remain material constraints. Climate-related changes in pollen seasons and urban air pollution are also influencing exposure patterns and clinical demand.

How Artificial Intelligence Is Changing Allergy Care

Artificial intelligence can support allergy treatment by identifying patterns in electronic health records, improving interpretation of symptom and exposure data, assisting image-based assessment of dermatologic manifestations, and helping clinicians prioritize patients for specialist evaluation. Predictive tools may also improve medication adherence support and identify individuals at heightened risk of severe reactions. Safe adoption requires representative training data, transparent validation, privacy safeguards, clinician oversight, and clear separation between decision support and autonomous diagnosis. Bias is a particular concern where underdiagnosed populations and low-resource settings are poorly represented in datasets.

Regional Insights Across Allergy Treatment Markets

North America combines broad access to specialist care, established biologic and immunotherapy pathways, and extensive consumer use of nonprescription products, while cost, insurance coverage, and care fragmentation affect treatment continuity. Europe emphasizes guideline-based care, pharmacovigilance, and harmonized regulatory principles, but access differs across national systems. Asia-Pacific presents substantial variation in diagnosis, urban exposure, healthcare infrastructure, and treatment preferences; Japan, Australia, South Korea, China, and India each reflect distinct care pathways. Latin America is influenced by uneven specialist availability, public-sector capacity, and medicine affordability. The Middle East is seeing greater attention to allergy diagnosis and chronic respiratory care, alongside differences in reimbursement and clinical resources. Africa faces substantial gaps in specialist services, diagnostic infrastructure, and medicine access, making primary-care integration and locally appropriate protocols especially important.

Group-Level Perspectives: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN countries are navigating varied healthcare capacity, tropical and urban exposure profiles, and uneven access to allergy specialists, creating a strong case for shared training and scalable diagnostic pathways. BRICS members encompass large and diverse populations, with priorities spanning affordability, domestic manufacturing, primary-care integration, and improved recognition of underdiagnosed disease. The European Union benefits from coordinated scientific and regulatory structures, although national reimbursement and service delivery continue to differ. G7 systems generally have advanced clinical infrastructure and research capabilities, but face aging populations, chronic disease complexity, and pressure to improve value and access. GCC countries are investing in modern healthcare services while addressing environmental exposures, workforce specialization, and cross-border care coordination. NATO members vary considerably in health-system design, yet operational readiness, continuity of care, and standardized emergency management are relevant shared considerations.

Country Insights: Diverse Priorities in Allergy Treatment

Australia and Canada emphasize guideline-led care, specialist access across dispersed populations, and management of environmental and food-allergy risks. The United States has broad therapeutic choice and specialist expertise, with affordability, insurance design, and care coordination remaining important issues. Mexico and Brazil continue to require wider diagnostic access and stronger integration between primary and specialist services. The United Kingdom, France, Germany, Italy, and Spain operate within mature European clinical environments, but differ in reimbursement, referral pathways, and regional service capacity. China and India are expanding healthcare access and diagnostic capability while addressing major urban-rural disparities. Japan and South Korea combine advanced medical infrastructure with strong interest in precision diagnostics and structured chronic-care management. Russia’s allergy treatment environment is shaped by regional access differences, clinical capacity, and medicine availability.

Strategic Priorities for Industry Leaders

Industry leaders should prioritize evidence-based therapies that address unmet needs across allergic rhinitis, asthma-related allergy, atopic dermatitis, food allergy, and severe hypersensitivity. Strengthening diagnostic partnerships, adherence programs, patient education, and clinician training can improve outcomes beyond product selection alone. Organizations should design access strategies around local reimbursement, primary-care workflows, and supply reliability rather than assuming uniform adoption. Responsible AI governance should include clinical validation, bias testing, cybersecurity, explainability, and post-deployment monitoring. Collaboration with regulators, hospitals, pharmacies, patient organizations, and public-health agencies can support safer use, earlier diagnosis, and more consistent treatment pathways.

Research Methodology for the Allergy Treatment Executive Summary

This executive summary uses a structured review of the allergy treatment landscape, organizing findings by therapeutic evolution, technology adoption, geography, economic grouping, and country context. Evidence should be assessed through peer-reviewed clinical literature, regulatory publications, public-health surveillance, professional guidelines, reimbursement documents, and validated healthcare datasets. Findings are interpreted qualitatively to identify documented patterns in diagnosis, treatment access, clinical practice, and innovation. The approach excludes unsupported market sizing and emphasizes source quality, recency, transparency, comparability, and acknowledgment of regional data limitations.

Conclusion: Building More Accessible and Personalized Allergy Care

Allergy treatment is evolving toward earlier identification, individualized therapy, disease modification, and digitally supported follow-up. Progress will depend not only on new medicines and diagnostics, but also on dependable primary-care pathways, specialist training, affordability, adherence support, and emergency preparedness. Regional and country differences require locally adapted strategies, while responsible use of artificial intelligence can strengthen-rather than replace-clinical judgment. Leaders that combine scientific rigor with access planning and patient-centered delivery will be best positioned to improve allergy outcomes across diverse health systems.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Allergy Treatment Market, by Treatment Type
7.1. Introduction
7.2. Allergen Immunotherapy
7.2.1. Subcutaneous Immunotherapy
7.2.2. Sublingual Immunotherapy
7.3. Over The Counter Drugs
7.3.1. Antihistamines
7.3.2. Decongestants
7.3.3. Eye Drops
7.3.4. Nasal Sprays
7.4. Prescription Drugs
7.4.1. Antihistamines
7.4.2. Combination Drugs
7.4.3. Corticosteroids
7.4.4. Leukotriene Modifiers
7.4.5. Mast Cell Stabilizers
8. Allergy Treatment Market, by Allergy Type
8.1. Introduction
8.2. Drug
8.3. Food
8.3.1. Milk
8.3.2. Peanuts
8.3.3. Shellfish
8.3.4. Tree Nuts
8.4. Respiratory
8.4.1. Dust Mites
8.4.2. Mold Spores
8.4.3. Pet Dander
8.4.4. Pollens
8.5. Skin
9. Allergy Treatment Market, by Distribution Channel
9.1. Introduction
9.2. Online
9.3. Offline
10. Allergy Treatment Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Homecare
10.4. Hospitals
11. Allergy Treatment Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Allergy Treatment Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Allergy Treatment Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. AbbVie Inc.
15.2. Alembic Pharmaceuticals Limited
15.3. ALK-Abelló A/S
15.4. Allergy Therapeutics plc
15.5. Almirall, S.A.
15.6. Angany Inc.
15.7. ARS Pharmaceuticals, Inc.
15.8. AstraZeneca PLC
15.9. Bausch Health Companies Inc.
15.10. Bayer AG
15.11. Boehringer Ingelheim International GmbH
15.12. Cipla Limited
15.13. DBV Technologies S.A.
15.14. Dr. Reddy's Laboratories Limited
15.15. F. Hoffmann-La Roche Ltd
15.16. Glenmark Pharmaceuticals Limited
15.17. GSK plc
15.18. Hikma Pharmaceuticals PLC
15.19. Johnson & Johnson
15.20. Lupin Limited
15.21. Merck KGaA
15.22. Novartis AG
15.23. Optinose, Inc.
15.24. Pfizer Inc.
15.25. Regeneron Pharmaceuticals, Inc.
15.26. Sanofi S.A.
15.27. Stallergenes Greer plc
15.28. Sun Pharmaceutical Industries Limited
15.29. Teva Pharmaceutical Industries Limited
15.30. Viatris Inc.
16. Key Experts
List of Figures
FIGURE 1. Global Allergy Treatment Market, Years Considered for the Study
FIGURE 2. Global Allergy Treatment Market, Research Design
FIGURE 3. Global Allergy Treatment Market, Research Framework
FIGURE 4. Global Allergy Treatment Market, Data Triangulation
FIGURE 5. Global Allergy Treatment Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Allergy Treatment Market Size, by Treatment Type, 2025 vs 2032 (%)
FIGURE 7. Global Allergy Treatment Market Size, by Treatment Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Allergy Treatment Market Size, by Allergy Type, 2025 vs 2032 (%)
FIGURE 9. Global Allergy Treatment Market Size, by Allergy Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Allergy Treatment Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Allergy Treatment Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Allergy Treatment Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Allergy Treatment Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Allergy Treatment Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Allergy Treatment Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Allergy Treatment Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Allergy Treatment Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Allergy Treatment Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Allergy Treatment Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Allergy Treatment Market Segmentation & Coverage
TABLE 2. Global Allergy Treatment Market Size, 2017-2032 (USD Million)
TABLE 3. Global Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 4. Global Allergen Immunotherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Allergen Immunotherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Allergen Immunotherapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Subcutaneous Immunotherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Subcutaneous Immunotherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Subcutaneous Immunotherapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Sublingual Immunotherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Sublingual Immunotherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Sublingual Immunotherapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Over The Counter Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Over The Counter Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Over The Counter Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Antihistamines Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Antihistamines Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Antihistamines Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Decongestants Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Decongestants Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Decongestants Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Eye Drops Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Eye Drops Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Eye Drops Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Nasal Sprays Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Nasal Sprays Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Nasal Sprays Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Prescription Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Prescription Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Prescription Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Antihistamines Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Antihistamines Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Antihistamines Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Combination Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Combination Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Combination Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Corticosteroids Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Corticosteroids Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Corticosteroids Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Leukotriene Modifiers Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Leukotriene Modifiers Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Leukotriene Modifiers Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Mast Cell Stabilizers Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Mast Cell Stabilizers Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Mast Cell Stabilizers Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 47. Global Drug Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Drug Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Drug Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Food Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Food Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Food Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Milk Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Milk Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Milk Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Peanuts Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Peanuts Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Peanuts Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Shellfish Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Shellfish Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Shellfish Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Tree Nuts Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Tree Nuts Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Tree Nuts Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Respiratory Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Respiratory Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Respiratory Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Dust Mites Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Dust Mites Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Dust Mites Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Mold Spores Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Mold Spores Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Mold Spores Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Pet Dander Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Pet Dander Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Pet Dander Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Pollens Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Pollens Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Pollens Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Skin Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Skin Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Skin Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 84. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Homecare Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Homecare Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Homecare Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Allergy Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Allergy Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. North America Allergy Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. North America Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 113. North America Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 114. North America Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 115. North America Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 116. North America Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 117. North America Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 118. North America Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 119. North America Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 120. North America Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. Latin America Allergy Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Latin America Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 123. Latin America Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 124. Latin America Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 125. Latin America Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 126. Latin America Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 127. Latin America Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 128. Latin America Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 129. Latin America Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 130. Latin America Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Europe Allergy Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Europe Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 133. Europe Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 134. Europe Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 135. Europe Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 136. Europe Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 137. Europe Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 138. Europe Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 139. Europe Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 140. Europe Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. Middle East Allergy Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Middle East Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 143. Middle East Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 144. Middle East Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 145. Middle East Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 146. Middle East Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 147. Middle East Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 148. Middle East Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 149. Middle East Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 150. Middle East Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. Africa Allergy Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Africa Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 153. Africa Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 154. Africa Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 155. Africa Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 156. Africa Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 157. Africa Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 158. Africa Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 159. Africa Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 160. Africa Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Global Allergy Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. ASEAN Allergy Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. ASEAN Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 164. ASEAN Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 165. ASEAN Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 166. ASEAN Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 167. ASEAN Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 168. ASEAN Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 169. ASEAN Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 170. ASEAN Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 171. ASEAN Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. GCC Allergy Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. GCC Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 174. GCC Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 175. GCC Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 176. GCC Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 177. GCC Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 178. GCC Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 179. GCC Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 180. GCC Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 181. GCC Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. European Union Allergy Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. European Union Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 184. European Union Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 185. European Union Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 186. European Union Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 187. European Union Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 188. European Union Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 189. European Union Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 190. European Union Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 191. European Union Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. BRICS Allergy Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 193. BRICS Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 194. BRICS Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 195. BRICS Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 196. BRICS Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 197. BRICS Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 198. BRICS Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 199. BRICS Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 200. BRICS Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 201. BRICS Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. G7 Allergy Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. G7 Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 204. G7 Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 205. G7 Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 206. G7 Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 207. G7 Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 208. G7 Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 209. G7 Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 210. G7 Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 211. G7 Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. NATO Allergy Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 213. NATO Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 214. NATO Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 215. NATO Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 216. NATO Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 217. NATO Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 218. NATO Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 219. NATO Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 220. NATO Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 221. NATO Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Global Allergy Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 223. United States Allergy Treatment Market Size, 2017-2032 (USD Million)
TABLE 224. United States Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 225. United States Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 226. United States Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 227. United States Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 228. United States Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 229. United States Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 230. United States Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 231. United States Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 232. United States Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. Canada Allergy Treatment Market Size, 2017-2032 (USD Million)
TABLE 234. Canada Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 235. Canada Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 236. Canada Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 237. Canada Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 238. Canada Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 239. Canada Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 240. Canada Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 241. Canada Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 242. Canada Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Mexico Allergy Treatment Market Size, 2017-2032 (USD Million)
TABLE 244. Mexico Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 245. Mexico Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 246. Mexico Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 247. Mexico Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 248. Mexico Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 249. Mexico Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 250. Mexico Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 251. Mexico Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 252. Mexico Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. Brazil Allergy Treatment Market Size, 2017-2032 (USD Million)
TABLE 254. Brazil Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 255. Brazil Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 256. Brazil Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 257. Brazil Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 258. Brazil Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 259. Brazil Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 260. Brazil Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 261. Brazil Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 262. Brazil Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. United Kingdom Allergy Treatment Market Size, 2017-2032 (USD Million)
TABLE 264. United Kingdom Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 265. United Kingdom Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 266. United Kingdom Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 267. United Kingdom Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 268. United Kingdom Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 269. United Kingdom Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 270. United Kingdom Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 271. United Kingdom Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 272. United Kingdom Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. Germany Allergy Treatment Market Size, 2017-2032 (USD Million)
TABLE 274. Germany Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 275. Germany Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 276. Germany Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 277. Germany Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 278. Germany Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 279. Germany Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 280. Germany Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 281. Germany Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 282. Germany Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. France Allergy Treatment Market Size, 2017-2032 (USD Million)
TABLE 284. France Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 285. France Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 286. France Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 287. France Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 288. France Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 289. France Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 290. France Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 291. France Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 292. France Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 293. Russia Allergy Treatment Market Size, 2017-2032 (USD Million)
TABLE 294. Russia Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 295. Russia Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 296. Russia Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 297. Russia Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 298. Russia Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 299. Russia Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 300. Russia Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 301. Russia Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 302. Russia Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. Italy Allergy Treatment Market Size, 2017-2032 (USD Million)
TABLE 304. Italy Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 305. Italy Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 306. Italy Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 307. Italy Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 308. Italy Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 309. Italy Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 310. Italy Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 311. Italy Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 312. Italy Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. Spain Allergy Treatment Market Size, 2017-2032 (USD Million)
TABLE 314. Spain Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 315. Spain Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 316. Spain Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 317. Spain Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 318. Spain Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 319. Spain Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 320. Spain Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 321. Spain Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 322. Spain Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. China Allergy Treatment Market Size, 2017-2032 (USD Million)
TABLE 324. China Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 325. China Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 326. China Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 327. China Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 328. China Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 329. China Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 330. China Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 331. China Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 332. China Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 333. India Allergy Treatment Market Size, 2017-2032 (USD Million)
TABLE 334. India Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 335. India Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 336. India Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 337. India Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 338. India Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 339. India Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 340. India Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 341. India Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 342. India Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 343. Japan Allergy Treatment Market Size, 2017-2032 (USD Million)
TABLE 344. Japan Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 345. Japan Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 346. Japan Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 347. Japan Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 348. Japan Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 349. Japan Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 350. Japan Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 351. Japan Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 352. Japan Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 353. Australia Allergy Treatment Market Size, 2017-2032 (USD Million)
TABLE 354. Australia Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 355. Australia Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 356. Australia Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 357. Australia Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 358. Australia Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 359. Australia Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 360. Australia Allergy Treatment Market Size, by Respiratory, 2017-2032 (USD Million)
TABLE 361. Australia Allergy Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 362. Australia Allergy Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 363. South Korea Allergy Treatment Market Size, 2017-2032 (USD Million)
TABLE 364. South Korea Allergy Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 365. South Korea Allergy Treatment Market Size, by Allergen Immunotherapy, 2017-2032 (USD Million)
TABLE 366. South Korea Allergy Treatment Market Size, by Over The Counter Drugs, 2017-2032 (USD Million)
TABLE 367. South Korea Allergy Treatment Market Size, by Prescription Drugs, 2017-2032 (USD Million)
TABLE 368. South Korea Allergy Treatment Market Size, by Allergy Type, 2017-2032 (USD Million)
TABLE 369. South Korea Allergy Treatment Market Size, by Food, 2017-2032 (USD Million)
TABLE 370. South Korea Allergy Treatment Market S

Companies Mentioned

  • AbbVie Inc.
  • Alembic Pharmaceuticals Limited
  • ALK-Abelló A/S
  • Allergy Therapeutics plc
  • Almirall, S.A.
  • Angany Inc.
  • ARS Pharmaceuticals, Inc.
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cipla Limited
  • DBV Technologies S.A.
  • Dr. Reddy's Laboratories Limited
  • F. Hoffmann-La Roche Ltd
  • Glenmark Pharmaceuticals Limited
  • GSK plc
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson
  • Lupin Limited
  • Merck KGaA
  • Novartis AG
  • Optinose, Inc.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi S.A.
  • Stallergenes Greer plc
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Limited
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages189
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 36.35 Billion
Forecasted Market Value ( USD ) by 2032 $ 62.69 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Allergy Drugs Market - Global Forecast 2026-2032 - Product Image

Allergy Drugs Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Allergy Diagnostic & Treatment Market - Global Forecast 2026-2032 - Product Image

Allergy Diagnostic & Treatment Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Allergy Immunotherapies Market Size, Share, Trends and Forecast by Treatment Type, Allergy Type, Distribution Channel, and Region, 2026-2034 - Product Image

Allergy Immunotherapies Market Size, Share, Trends and Forecast by Treatment Type, Allergy Type, Distribution Channel, and Region, 2026-2034

  • Report
  • 145 Pages
  • Global
From
Allergy Immunotherapy - Global Strategic Business Report - Product Image

Allergy Immunotherapy - Global Strategic Business Report

  • Report
  • 266 Pages
  • Global
From
Anti-Allergy Drugs - Global Strategic Business Report - Product Image

Anti-Allergy Drugs - Global Strategic Business Report

  • Report
  • 168 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.